Calculation of Filing Fee Table
Form S-1
Mineralys Therapeutics, Inc.
Table 1 - Newly Registered Securities
| | | | | | | | | | | | | | | | | | | | | | | |
Security Type | Security Class Title | Fee Calculation Rule | Amount Registered(1)(2) | Proposed Maximum Offering Price Per Share | Maximum Aggregate Offering Price(3) | Fee Rate | Amount of Registration Fee |
Equity | Common Stock, par value $0.0001 per share | Rule 457(a) | 2,300,000 | $16.00 | $36,800,000 | 0.00011020 | $4,056 |
Total Offering Amounts | | — | $36,800,000 | 0.00011020 | $4,056 |
Total Fees Previously Paid | | — | — | — | — |
Total Fees Offsets | | — | — | — | — |
Net Fee Due | | — | — | — | $4,056 |
(1) The registrant previously registered securities with a proposed maximum aggregate offering price not to exceed $184,000,000 on a Registration Statement on Form S-1 (File No. 333-269282), which was declared effective by the Securities and Exchange Commission on February 9, 2023. In accordance with Rule 462(b) promulgated under the Securities Act of 1933, as amended, an additional amount of securities having a proposed maximum aggregate offering price of $36,800,000 is hereby registered, which includes the shares of common stock that the underwriters have the option to purchase.
(2) Includes 300,000 shares of common stock that the underwriters have the option to purchase.
(3) Estimated solely for purposes of computing the amount of the registration fee pursuant to Rule 457(a) under the Securities Act of 1933, as amended.